The genomic and evolutionary landscapes of anaplastic thyroid carcinoma

Peter YF. Zeng, Stephenie D. Prokopec, Stephen Y. Lai, +65

Cell Reports

ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition

Kara M. Ruicci, Nicole Pinto, Mohammed Imran Khan, +6

Oral Oncology

Signal TransductionSignaling PathwayCell RegulationMolecular RegulationNatural Sciences +9

Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer

Farhad Ghasemi, Morgan Black, Frederick S. Vizeacoumar, +15

Oncotarget

Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status

Farhad Ghasemi, Stephenie D. Prokopec, Danielle MacNeil, +17

JCI Insight

Tobacco ControlMutational AnalysisSomatic VariantMedicinePathology +12

Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition

Kara M. Ruicci, Paul Plantinga, Nicole Pinto, +10

Molecular Oncology

Cell DeathCancer BiologyTumor BiologyMtorc2 DisruptionSignaling Pathway +14

Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High‐intensity Aerobic and resistance exercise for Metastatic castrate‐resistant Prostate cancer

Stacey A. Kenfield, Erin L. Van Blarigan, Neil Panchal, +20

Cancer Medicine

Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer

Anthony C. Nichols, Morgan Black, John Yoo, +5

BMC Pharmacology and Toxicology

Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models

Nicole Pinto, Stephenie D. Prokopec, Frederick S. Vizeacoumar, +13

PLoS ONE

OncologyPotent InhibitorMedicineJak2 Inhibitor LestaurtinibThyroid Disease +12

A controlled trial of HNSCC patient‐derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth

Kara M. Ruicci, Jalna Meens, Ren Sun, +10

International Journal of Cancer

Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival

Neil Mundi, Stephenie D. Prokopec, Farhad Ghasemi, +19

Cancers of the Head & Neck